Research reveals a osteoporosis medicine is expected to be used in the breast cancer treatment

Research reveals a osteoporosis medicine is expected to be used in the breast cancer treatment
Research reveals a osteoporosis medicine is expected to be used in the breast cancer treatment
Special despatch of October 2 of www.xinhuanet.com London (reporter is yellow) American and Austrian researcher said a few days ago, they found a kind of protein related to breast cancer. The good news correlated to this is, researchers have found this kind of protein will cause osteoporosis and already research and develop, direct against the clinical medicine of it before this, so it is expected to treat the relevant medicine of osteoporosis and turn into and can treat the medicine of breast cancer quickly. New British Nature has published two reports finished by American and Austrian researcher respectively, they study independently but has obtained unanimous result. A few years ago, a lot of women had accepted that had dealt with involutional hormone to substitute the treatment, progestogen of artificial synthesis used in this course has led to the fact the morbidity of breast cancer rises. Two parts report that has both confirmed the reason behind this phenomenon, progestogen has been activated one kind to call the protein of R A N K L, thus bring out breast cancer. American researchers have tested that can inhibit the result in preventing and curing breast cancer of medicine of protein R A N K L function. , under the carcinogenic environment equally, mouse's morbidity probability of the breast cancer of experiment of taking relevant medicine was lower. And Austrian researchers use the experiment mouse that revise through the gene to carry on the experiment. Because the gene is changed, the function that protein R A N K L in mouse's body of these experiments can't bring into normal play, compared with ordinary experiment mouse, the morbidity probability that they make breast cancer in the likewise carcinogenic environment is lower too. It is introduced, different from needing to could be transferred to actual application for longer time in most basic research results, this discovery is expected to expedite the emergence of the new one and can be used in the medicine curing human breast cancer in short term. Research showed before this, protein R A N K L still related to osteoporosis, and researchers had already developed the clinical medicine of osteoporosis directed against this kind of protein. Perhaps only need the change a little, can use this kind of osteoporosis medicine for treating breast cancer.


|